NASDAQ Biotechnology Share Price

Index

Market Closed - Nasdaq 02:46:01 08/10/2026 am IST			5-day change	1st Jan Change
6,879.32 ^PTS	+0.28%		-3.31%	+20.54%

Current month	-3.31%
1 month	-4.93%

02:09pm	Argenx to Discontinue Late-Stage Sjogren's Disease Trial; Shares Down Pre-Bell	MT
01:13pm	Grail Insider Sold Shares Worth $3,457,585, According to a Recent SEC Filing	MT
01:13pm	Grail Insider Sold Shares Worth $1,152,528, According to a Recent SEC Filing	MT
11:09am	Argenx to Discontinue Late-stage Study of Subcutaneous Efgartigimod in Sjögren's Disease	MT
11:07am	Argenx's Celiac Drug Meets Primary Endpoint in Mid-stage Trial	MT
08/10	4D Molecular Therapeutics Insider Sold Shares Worth $753,937, According to a Recent SEC Filing	MT
08/10	Biontech Insider Sold Shares Worth $2,300,633, According to a Recent SEC Filing	MT
08/10	Amylyx Pharmaceuticals Insider Sold Shares Worth $830,904, According to a Recent SEC Filing	MT
07/10	Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule	MT
07/10	PTC Therapeutics Retains Significant Firepower for Bolt-On Deals, RBC Capital Markets Says	MT

No results match your criteria

Name	Change	AuM	5-day change
INVESCO NASDAQ BIOTECH UCITS ETF ACC - USD	-1.51%	470 M€	-2.97%
ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD	-1.82%	1,079 M€	-3.16%
PROSHARES ULTRA NASDAQ BIOTECHNOLOGY ETF - USD	+0.53%	90 M€	-6.92%